Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive artesunate, ≈60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort...

Full description

Bibliographic Details
Main Authors: Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, Flavie Ader, Camille Roussel, Romain Sonneville, Julien Mayaux, Sophie Matheron, Adela Angoulvant, Benjamin Wyplosz, Christophe Rapp, Thierry Pistone, Bénédicte Lebrun-Vignes, Eric Kendjo, Martin Danis, Sandrine Houzé, François Bricaire, Dominique Mazier, Pierre Buffet, Eric Caumes
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-05-01
Series:Emerging Infectious Diseases
Subjects:
hemolysis
hemolytic anemia
malaria
artesunate
delayed-onset
safety
Online Access:https://wwwnc.cdc.gov/eid/article/21/5/14-1171_article

Internet

https://wwwnc.cdc.gov/eid/article/21/5/14-1171_article

Similar Items